GR-389988
|
G610646-25mg
|
Moligand™ |
1788906-96-6 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 218,231
|
G610645-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 218,231
|
G610645-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 196429
|
G610644-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 196429
|
G610644-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 175737
|
G610643-5mg
|
Moligand™ |
176860-26-7 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 175737
|
G610643-25mg
|
Moligand™ |
176860-26-7 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
4,4,4-三氟-1-(2-噻吩基)-1,2,3-丁三酮 2-[(3-甲基苯基)腙]
|
G610642-5mg
|
Moligand™, ≥96% |
263890-70-6 |
5mg
|
¥ 299.9
|
现货 |
阿拉丁 |
4,4,4-三氟-1-(2-噻吩基)-1,2,3-丁三酮 2-[(3-甲基苯基)腙]
|
G610642-25mg
|
Moligand™, ≥96% |
263890-70-6 |
25mg
|
¥ 949.9
|
现货 |
阿拉丁 |
GR 144053
|
G610641-5mg
|
Moligand™ |
201304-22-5 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 144053
|
G610641-25mg
|
Moligand™ |
201304-22-5 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 128107
|
G610639-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 128107
|
G610639-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 125487
|
G610636-5mg
|
Moligand™ |
144625-67-2 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 125487
|
G610636-25mg
|
Moligand™ |
144625-67-2 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GR 113808
|
G610635-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GR 113808
|
G610635-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GPR4 antagonist 3b
|
G610633-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
GPR4 antagonist 3b
|
G610633-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
GPI-1046
|
G610630-5mg
|
Moligand™, ≥98% |
186452-09-5 |
5mg
|
¥ 1199.9
|
现货 |
阿拉丁 |
GPI-1046
|
G610630-25mg
|
Moligand™, ≥98% |
186452-09-5 |
25mg
|
¥ 3699.9
|
现货 |
阿拉丁 |
Go 7874
|
G610629-5mg
|
Moligand™ |
153207-86-4 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
Go 7874
|
G610629-25mg
|
Moligand™ |
153207-86-4 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
gosogliptin
|
G610628-5mg
|
Moligand™ |
869490-23-3 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |